Sigrid Therapeutics Announces First Patient Treated with SiPore21® Medical Device for Sustained Diabetes and Obesity Control

Posted on by

SiPore21® Silica “Molecular Sieves” Offer a Promising Non-Pharmaceutical Alternative SHINE Trial Marks a Milestone in Prediabetes and Weight Control Research STOCKHOLM, Oct. 9, 2023 /PRNewswire/ — Sigrid Therapeutics announces the commencement of the SHINE clinical trial for SiPore21® –…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.